Remark
.
IPO Date & Price
IPO Date: 2011-04-19
Offer price/share: $16 x 5.8M = $92.8M
Underwriters
Joint Book Runner: Morgan Stanley, BofA Merrill Lynch, Jefferies & Co.
Co Manager: Needham & Co., RBC Capital Markets
Business
Sector: N/A
Industry: N/A
Full Time Employees: N/A
Founded: 2006
Sagent Pharmaceuticals, Inc., a specialty injectables company, engages in developing, manufacturing, sourcing, and marketing injectable pharmaceutical products in the United States and internationally. It offers injectable products in the therapeutic areas of cardiovascular, anti-infective/antibacterial, antineoplastic agent, and antiemetic. The company’s products also include heparin sodium injections; and ANEclear, a disposable anesthesia recovery device that enables clinicians to remove unwanted anesthetic gases from their patients' brain, blood, and lungs at the end of the surgical procedure. It offers various packaging options, including premix bags, prefilled syringes, single-dose vials, and pharmacy bulk package vials. Sagent Pharmaceuticals, Inc. was founded in 2006 and is based in Schaumburg, Illinois. Sagent Pharmaceuticals, Inc. operates as a subsidiary of Sagent Holding Co
Yahoo: http://finance.yahoo.com/q/pr?s=SGNT
No comments:
Post a Comment